Twenty-two recurrent calcium stone formers had 24-h urinary oxalate excretions on their home diets which were significantly greater than those of 30 normal subjects «()·4X±()·23 rnrnol/d; mean±SD compared with 0·31±0·11; P<IHII). The stone formers also demonstrated marked day to day variability in oxalate excretion indicating that a single normal urinary oxalate measurement did not exclude significant hyperoxaluria at other times.
SUMMi\I(Y.
Twenty-two recurrent calcium stone formers had 24-h urinary oxalate excretions on their home diets which were significantly greater than those of 30 normal subjects «()·4X±()·23 rnrnol/d; mean±SD compared with 0·31±0·11; P<IHII). The stone formers also demonstrated marked day to day variability in oxalate excretion indicating that a single normal urinary oxalate measurement did not exclude significant hyperoxaluria at other times.
On a hospital diet containing J()()() mg calcium per day, urinary oxalate excretion fell significantly from 0·4X±0·23 mmol/d to ()·32±O·12; P<O·Ol. As the urinary calcium excretion in and out of hospital was similar, it seems unlikely that low calcium intake at home was responsible for the hyperoxaluria.
All patients had recurrent symptomatic stone disease and had been advised to avoid foods rich in oxalate. Whilst poor compliance is a possible explanation for the variability in oxalate excretion. we believe it is more likely that there is an inadvertent intake of oxalogenic precursors in their diet. As normal subjects do not demonstrate hypcroxaluria on similar home diets, stone formers may have a metabolic defect in the handling of these precursors.
Approximately XO-YO'X. of renal stones in westernised societies contain calcium. I. 2 Calcium oxalate is a major constituent of these stones and increased urinary oxalate excretion is one of the major factors predisposing an individual to calcium nephrolithiasis.' For this reason 24-h urinary oxalate excretion is often measured routinely in patients with renal calculi. However. the factors which modulate oxalate excretion in these patients remain poorly defined.
In the current study the daily urinary excretion of oxalate was measured in recurrent calcium stone formers on their usual diets at home at about monthly intervals to determine its variability and therefore its clinical usefulness. In addition. oxalate excretion was assessed in these patients on controlled hospital diets containing ISO and J()()() mg of calcium. The IOI)() rng/d diet approximates the mean normal daily calcium intake. This has enabled us to Correspondence compare the effect of dietary calcium with other dietary constituents on urinary oxalate excretion.
Methods

SUBJECTS
The 22 patients studied had a history of recurrent calcium nephrolithiasis. This group comprised 16 men and six women with ages ranging from 22 to 66 years. All patients had recent radio-opaque stones demonstrable on abdominal X-rays. Stones obtained from nine of the patients and analysed by a wet chemical method" indicated the presence of mixed calcium phosphate/oxalate calculi. None of the patients had evidence of hyperparathyroidism. enteric hyperoxaluria or vitamin D intoxication. All could acidify their urine to a urinary pH<5·3. following a standard ammonium chloride loading test thereby excluding renal tubular acidosis", At the time of the experiments, all patients were healthy and had normal renal function as assessed by plasma creatinine concentration.
Seventeen of these patients had multiple (2-6) 24-h urinary oxalate estimations made as out-patients. The time interval between urinary oxalate measurements was approximately one month. Thirty normal subjects were used as controls for the out-patient study. This group comprised equal numbers of males and females with ages ranging from 20 to 50 years.
We divided the patients into two groups. Eight patients with urinary calcium excretion exceeding 7·5 mmol/d on the 1000 mg/d calcium diet in hospital were termed hypercalciuric patients. The remaining 14 patients had urinary calcium excretion below 7·5 mmol/d on the same diet and were termed normocalcuric patients. None of the patients had urinary calcium exceeding 7·5 mmol/d on the ISO rug/day calcium diet.
AN A L YTICA L M ETHO 1)5
Twenty-four hour urines were preserved with either 50 mL hydrochloric acid (5 mol/L) or O· 2-0·6 mmol sodium thimerosal plus 20-25 mmol disodium ethylenediaminetetracetate (EDTA) to prevent ascorbate instability and oxalate generation." A tripartite urine container? was used where more than one preservative was required. Oxalate concentrations were measured in duplicate by an automated oxalate decarboxylase, formate dehydrogenase specific enzymatic method." Between-run and within-run precisions were 7·3 and 3·4'X" respectively, and the 97th percentile for 30 normal urine samples was O·S mmol/d. The specificity of this method has been validated by comparison with a rate enzymatic method and a specific gas chromatographic method." Calcium was measured by EGTA titration of the fluorescent calcein complex and creatinine by the Jaffe rate reaction.
food of oxalate and its precursors. A detailed dietary assessment of these diets using appropriate tables II. 12 indicated that the out-patient diets had similar animal and vegetable protein content and caloric intake to the in-patient diets. There were no unusual or exotic foodstuffs taken by the patients in the out-patient study that may have been an unrecognised source of oxalate. A significant difference between the diets was the ascorbate content with the in-patient diet containing 411-45 mg/d and the out-patient diet approximately 21K) rng/d, Thirty normal subjects were also studied on their usual diets. There were no significant differences between the outpatient diets of the stone formers and the diets of the control subjects in relation to these nutrients.
Patients were pre-equilibrated on low (150 mg; 3·75 mmol) calcium diet for 2 days before urine collections were made for the following 2 days on this diet. After this, in hospital diets were supplemented with 600 mg tablets of calcium gluconate (4·5 tablets tds; Sigma Pharmaceuticals. Melbourne. Australia) to increase total daily calcium intake to HIl)O mg (25 mmol) and this high calcium diet was maintained for a further 2 days. In hospital. 24-h urine collections were made each day on the low and high calcium diets (four collections in all). The detailed compositions of these 150 and 1000 mg calcium diets in hospital arc available from the authors. The 10(11) mg diet approximates the average community calcium intake':' being contained for example in 600 ml, of milk.
STATISTICS
In order to compare the variability in oxalate and creatinine excretion, an index of variability was derived as follows:
A comparison of the index of variability between creatinine and oxalate excretions was made using the Wilcoxon signed rank test for unpaired observations (two-tailed probability);!"
To compare the oxalate excretions of inpatients against out-patients and out-patients against control subjects a non-parametric DIETS We measured the 24-h urinary excretion of oxalate, calcium and creatinine ill our patients both as out-patients on their usual diets and in hospital on two defined diets containing ISO and 1000 mg calcium per day, respectively.
As out-patients, the recurrent stone formers were encouraged to avoid foodstuffs with high calcium or oxalate content!" and to maintain an increased fluid intake. The patients were keen to comply with these dietary directives because of the trauma associated with renal stones and the recurrent nature of their disease. However, one cannot be absolutely certain as to the compliance or their unwitting ingestion in
Wilcoxon signed rank test for unpaired observations (two-tailed probability) was used.'" The Wilcoxon signed rank test for paired observations was used to compare oxalate excretions on in-hospital high and low calcium diets (twotailed probability). The Chi squared test was used to compare the trends in oxalate excretion in hyper-and normo-calciuric patients in response to the 150 and HKKI mg diets."
Results
The 24-h urinary oxalate excretion in 22 patients with recurrent calcium nephrolithiasis consuming their usual diet at home is shown in Fig. I . The daily urinary oxalate excretion (mean±SD) was 0·4X±0·23. significantly greater (p<IHH) than that of 30 normal subjects whose excretion was 0·31 ±O·ll mmolld when they were also consuming their normal diets at home ( extremely variable. This variability in oxalate excretion was considerably greater than that found for creatinine excretion. For example. the index of variability (mean±SD) for outpatient oxalate excretions (60·9±36·3%) was significantly greater (P<O·002) than for the corresponding creatinine excretion (24·2±17·5%).
There was poor correlation between daily urinary oxalate and calcium excretion in the outpatient stone formers. both when considered together (r=0·02. n=54; P=NS) and when the hypercalciuric (r= -0·09. n=26 daily estimations) and normocalciuric patients (r=-O·13. n=28) were considered separately. The mean calcium excretion for these outpatients was 7·36±2·22 mmolld (mean±SD; Table 1 ).
Following admission to hospital for the formal controlled dietary calcium studies. maximal oxalate excretion fell in 19 of 22 patients with only six of 88 oxalate determinations (6'8%) in hospital exceeding 0·50 mmolld.
The out-patient urinary oxalate excretion was significantly higher (P<O·Ol) than that in hospital (0·48±0·23 I'S O·32±0·12 mmol/d: mean±SO). The mean 24-h urinary creatinine for the in-patient specimens (13-6±3-31) did not differ significantly from that for the outpatient specimens (14-46±3·S2 mmol/d). Table 1 summarises the urinary oxalate and calcium excretion in the respective groups on home diets. and hospital 150 mg and WOO mg calcium diets. The urinary calcium excretion on the home diets approximates that on the lO()() mg calcium diets in hospital. The mean (±SO) 24-h urine oxalate in hospital was relatively constant from day 1 to day 4 (O-34±O·14. 0-31±0-11. O'31±0-13, 0-31±0-1O mmol/d for the 4 days, respectively), indicating that the patients had equilibrated their oxalate excretion in relation to the hospital diets. The patients also appeared to change their urinary calcium excretion rapidly in response to the alteration in diet. On the first and second days of the low and high calcium diets calcium excretion was 4-1±I-S and 3-X±I-3; 6·6±2-2 and 7·6±2·6 mmolld respectively (mean±SO, n=22 determinations].
Seven of the eight patients in the hypercalciuric group decreased their oxalate excretion when placed on the lOOO mg calcium diet with mean oxalate excretion falling from 0-36±0-12 on 150 mgld calcium to 0-27±O-W mmol/d (mean±SO) on 1000 mg calcium (P«) .(I4; Table I ). In contrast, only three of the 14 normocalciuric patients showed a fall in urinary oxalate on the WOO mg calcium diet. In this group, mean urinary oxalate excretion was essentially constant being 0-30±IH2 (SO) on the low calcium diet and 0-33±0-12 (mmol/d) on the high calcium diet (P=NS). The trend in the oxalate excretion of these two groups (7 up, I down vs 3 up, II down) were significantly different (P<I),(II).
Discussion
The 24-h urinary oxalate excretion in recurrent calcium stone formers at home is significantly (P<O-Ol) greater than that of normal subjects at home. This confirms the findings made by other groups. 15 . III It is also significantly greater (P«) , (II) than that seen in recurrent calcium stone formers in hospital on defined ISO and 1000 mg calcium intakes (Table I ). In addition, we found that the 24-h urinary oxalate excretions of individual stone formers are highly variable (Fig. I) . The variability and the normalisation of excretion in hospital suggest that these patients <Ire responding to dietary factors; either oxalate itself or other dietary factors which can result in oxalogenesis. It also suggests that the finding of a single normal urinary oxalate in <I patient does not exclude the presence of clinically significant hyperoxaluria <It other times.
It is unlikely that the variable urinary oxalate excretion and hyperoxaluria seen in patients on their home diets was due to excessive oxalate intake since the patients were told to avoid foods high in oxalate content and this was confirmed by their dietary histories. It is also unlikely that a low calcium intake by patients at home was responsible for increasing their oxalate excretion since urinary calcium excretion with recurrent stone disease. 25 • 26 It remains to be seen what other dietary factors are also important in oxalogenesis.
at home was similar to that in hospital ( IIKKI mg calcium diet) where the urinary oxalate excrction was normal (Table I ). In addition. there was a poor correlation between calcium and oxalate excretion on the home diets and. further. low calcium diets in hospital did not provoke hyperoxaluria in these patients. Thus. although we could demonstrate a significant inverse relationship between calcium intake and oxalate excretion in our hypercalciuric group in hospital as reported by other groups.l'"!" this effect on oxalate excretion was small when compared to the changes seen between home and hospital. That the low calcium diet produced only minor increases in urinary oxalate excretion is not unexpected as its effect is mediated via dietary oxalate which under normal dietary oxalate loads contribute only about IO'X, «(l·(lS mmol/d) to urinary oxalate Il,.~11 Our results are therefore consistent with these observations.
Whibt dietary non-compliance is a possible explanation for our patients' hyperoxaluria, we believe that these patients with recurrent stone disease were well motivated and properly advised regarding the avoidance of food known to he high in oxalate. We therefore believe that their hyperoxaluria relates to the inadvertent ingestion of oxalate precursors in non-oxalate rich foods. As normal healthy individuals do not respond in this way. we abo believe that stone formers have a defect in metabolising these substances. It is not known what these oxalogenic substances arc except that they may be oxalate precursors or may accelerate oxalogenesis exclusively in stone patients. We arc currently attempting load studies on patients and normals in an attempt to define the dietary constituents responsible for the hyperoxaluria seen in recurrent stone formers. Results of some of these challenges have already heen reported using certain foodstuffs such as protein.~I carbohydrates.~~ascorbate,~J chocolates. rhubarb, tea and struwberries.!'' In recent dynamic loading studies using ascorbate we have found that some stone formers convert more of this precursor to oxalate than norrnais.i" This observation is significant in view of the higher ascorbate content of the out-patient diets (see Methods section) and may indicate that variations in dietary intake of ascorbate contribute to the variability in oxalate excretion seen in stone patients. A genetic-environmental predisposition to recurrent stone formation of this type is consistent with the high incidence of renal stones in first degree relatives of patients
